9% on placebo (RR 4.3
Your skepticism is valid
To the best of our knowledge, the present study is the first prospective study to show that 1,800 mg/day L-carnitine supplementation for 6 months exhibited favorable effects on chronic fatigue in patients with cirrhosis
In the phase 3 ESSENCE RCT, which included MASH patients with fibrosis stage F2/F3, semaglutide significantly improved histological activity, fibrosis markers, and cardiometabolic features after 72 weeks of treatment in comparison to placebo [81]
Yes, NICE CG173 recommends first-line treatments including duloxetine (60 mg once daily), gabapentin, pregabalin, or amitriptyline for diabetic peripheral neuropathic pain, all available on NHS prescription
COMMUNITY POLL Should Medicare cover GLP-1s like Wegovy and Zepbound for weight loss